Reduction of lipid accumulation rescues Bietti's crystalline dystrophy phenotypes

Masayuki Hata, Hanako O. Ikeda, Sachiko Iwai, Yuto Iida, Norimoto Gotoh, Isao Asaka, Kazutaka Ikeda, Yosuke Isobe, Aya Hori, Saori Nakagawa, Susumu Yamato, Makoto Arita, Nagahisa Yoshimura, Akitaka Tsujikawa

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Bietti's crystalline dystrophy (BCD) is an intractable and progressive chorioretinal degenerative disease caused by mutations in the CYP4V2 gene, resulting in blindness in most patients. Although we and others have shown that retinal pigment epithelium (RPE) cells are primarily impaired in patients with BCD, the underlying mechanisms of RPE cell damage are still unclear because we lack access to appropriate disease models and to lesion-affected cells from patients with BCD. Here, we generated human RPE cells from induced pluripotent stem cells (iPSCs) derived from patients with BCD carrying a CYP4V2 mutation and successfully established an in vitro model of BCD, i.e., BCD patient-specific iPSC-RPE cells. In this model, RPE cells showed degenerative changes of vacuolated cytoplasm similar to those in postmortem specimens from patients with BCD. BCD iPSC-RPE cells exhibited lysosomal dysfunction and impairment of autophagy flux, followed by cell death. Lipidomic analyses revealed the accumulation of glucosylceramide and free cholesterol in BCD-affected cells. Notably, we found that reducing free cholesterol by cyclodextrins or δ-tocopherol in RPE cells rescued BCD phenotypes, whereas glucosylceramide reduction did not affect the BCD phenotype. Our data provide evidence that reducing intracellular free cholesterol may have therapeutic efficacy in patients with BCD.

Original languageEnglish
Pages (from-to)3936-3941
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume115
Issue number15
DOIs
Publication statusPublished - 2018 Jan 1

Fingerprint

Retinal Pigment Epithelium
Phenotype
Lipids
Induced Pluripotent Stem Cells
Glucosylceramides
Cholesterol
Bietti Crystalline Dystrophy
Mutation
Tocopherols
Autophagy
Cyclodextrins
Blindness
Cytoplasm
Cell Death
Genes

Keywords

  • Bietti's crystalline dystrophy
  • Cholesterol
  • CYP4V2 gene
  • Induced pluripotent stem cells
  • Retinal pigment epithelium

ASJC Scopus subject areas

  • General

Cite this

Reduction of lipid accumulation rescues Bietti's crystalline dystrophy phenotypes. / Hata, Masayuki; Ikeda, Hanako O.; Iwai, Sachiko; Iida, Yuto; Gotoh, Norimoto; Asaka, Isao; Ikeda, Kazutaka; Isobe, Yosuke; Hori, Aya; Nakagawa, Saori; Yamato, Susumu; Arita, Makoto; Yoshimura, Nagahisa; Tsujikawa, Akitaka.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 115, No. 15, 01.01.2018, p. 3936-3941.

Research output: Contribution to journalArticle

Hata, M, Ikeda, HO, Iwai, S, Iida, Y, Gotoh, N, Asaka, I, Ikeda, K, Isobe, Y, Hori, A, Nakagawa, S, Yamato, S, Arita, M, Yoshimura, N & Tsujikawa, A 2018, 'Reduction of lipid accumulation rescues Bietti's crystalline dystrophy phenotypes', Proceedings of the National Academy of Sciences of the United States of America, vol. 115, no. 15, pp. 3936-3941. https://doi.org/10.1073/pnas.1717338115
Hata, Masayuki ; Ikeda, Hanako O. ; Iwai, Sachiko ; Iida, Yuto ; Gotoh, Norimoto ; Asaka, Isao ; Ikeda, Kazutaka ; Isobe, Yosuke ; Hori, Aya ; Nakagawa, Saori ; Yamato, Susumu ; Arita, Makoto ; Yoshimura, Nagahisa ; Tsujikawa, Akitaka. / Reduction of lipid accumulation rescues Bietti's crystalline dystrophy phenotypes. In: Proceedings of the National Academy of Sciences of the United States of America. 2018 ; Vol. 115, No. 15. pp. 3936-3941.
@article{eb3d798329e1405a9d14c112876b9cc9,
title = "Reduction of lipid accumulation rescues Bietti's crystalline dystrophy phenotypes",
abstract = "Bietti's crystalline dystrophy (BCD) is an intractable and progressive chorioretinal degenerative disease caused by mutations in the CYP4V2 gene, resulting in blindness in most patients. Although we and others have shown that retinal pigment epithelium (RPE) cells are primarily impaired in patients with BCD, the underlying mechanisms of RPE cell damage are still unclear because we lack access to appropriate disease models and to lesion-affected cells from patients with BCD. Here, we generated human RPE cells from induced pluripotent stem cells (iPSCs) derived from patients with BCD carrying a CYP4V2 mutation and successfully established an in vitro model of BCD, i.e., BCD patient-specific iPSC-RPE cells. In this model, RPE cells showed degenerative changes of vacuolated cytoplasm similar to those in postmortem specimens from patients with BCD. BCD iPSC-RPE cells exhibited lysosomal dysfunction and impairment of autophagy flux, followed by cell death. Lipidomic analyses revealed the accumulation of glucosylceramide and free cholesterol in BCD-affected cells. Notably, we found that reducing free cholesterol by cyclodextrins or δ-tocopherol in RPE cells rescued BCD phenotypes, whereas glucosylceramide reduction did not affect the BCD phenotype. Our data provide evidence that reducing intracellular free cholesterol may have therapeutic efficacy in patients with BCD.",
keywords = "Bietti's crystalline dystrophy, Cholesterol, CYP4V2 gene, Induced pluripotent stem cells, Retinal pigment epithelium",
author = "Masayuki Hata and Ikeda, {Hanako O.} and Sachiko Iwai and Yuto Iida and Norimoto Gotoh and Isao Asaka and Kazutaka Ikeda and Yosuke Isobe and Aya Hori and Saori Nakagawa and Susumu Yamato and Makoto Arita and Nagahisa Yoshimura and Akitaka Tsujikawa",
year = "2018",
month = "1",
day = "1",
doi = "10.1073/pnas.1717338115",
language = "English",
volume = "115",
pages = "3936--3941",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "15",

}

TY - JOUR

T1 - Reduction of lipid accumulation rescues Bietti's crystalline dystrophy phenotypes

AU - Hata, Masayuki

AU - Ikeda, Hanako O.

AU - Iwai, Sachiko

AU - Iida, Yuto

AU - Gotoh, Norimoto

AU - Asaka, Isao

AU - Ikeda, Kazutaka

AU - Isobe, Yosuke

AU - Hori, Aya

AU - Nakagawa, Saori

AU - Yamato, Susumu

AU - Arita, Makoto

AU - Yoshimura, Nagahisa

AU - Tsujikawa, Akitaka

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Bietti's crystalline dystrophy (BCD) is an intractable and progressive chorioretinal degenerative disease caused by mutations in the CYP4V2 gene, resulting in blindness in most patients. Although we and others have shown that retinal pigment epithelium (RPE) cells are primarily impaired in patients with BCD, the underlying mechanisms of RPE cell damage are still unclear because we lack access to appropriate disease models and to lesion-affected cells from patients with BCD. Here, we generated human RPE cells from induced pluripotent stem cells (iPSCs) derived from patients with BCD carrying a CYP4V2 mutation and successfully established an in vitro model of BCD, i.e., BCD patient-specific iPSC-RPE cells. In this model, RPE cells showed degenerative changes of vacuolated cytoplasm similar to those in postmortem specimens from patients with BCD. BCD iPSC-RPE cells exhibited lysosomal dysfunction and impairment of autophagy flux, followed by cell death. Lipidomic analyses revealed the accumulation of glucosylceramide and free cholesterol in BCD-affected cells. Notably, we found that reducing free cholesterol by cyclodextrins or δ-tocopherol in RPE cells rescued BCD phenotypes, whereas glucosylceramide reduction did not affect the BCD phenotype. Our data provide evidence that reducing intracellular free cholesterol may have therapeutic efficacy in patients with BCD.

AB - Bietti's crystalline dystrophy (BCD) is an intractable and progressive chorioretinal degenerative disease caused by mutations in the CYP4V2 gene, resulting in blindness in most patients. Although we and others have shown that retinal pigment epithelium (RPE) cells are primarily impaired in patients with BCD, the underlying mechanisms of RPE cell damage are still unclear because we lack access to appropriate disease models and to lesion-affected cells from patients with BCD. Here, we generated human RPE cells from induced pluripotent stem cells (iPSCs) derived from patients with BCD carrying a CYP4V2 mutation and successfully established an in vitro model of BCD, i.e., BCD patient-specific iPSC-RPE cells. In this model, RPE cells showed degenerative changes of vacuolated cytoplasm similar to those in postmortem specimens from patients with BCD. BCD iPSC-RPE cells exhibited lysosomal dysfunction and impairment of autophagy flux, followed by cell death. Lipidomic analyses revealed the accumulation of glucosylceramide and free cholesterol in BCD-affected cells. Notably, we found that reducing free cholesterol by cyclodextrins or δ-tocopherol in RPE cells rescued BCD phenotypes, whereas glucosylceramide reduction did not affect the BCD phenotype. Our data provide evidence that reducing intracellular free cholesterol may have therapeutic efficacy in patients with BCD.

KW - Bietti's crystalline dystrophy

KW - Cholesterol

KW - CYP4V2 gene

KW - Induced pluripotent stem cells

KW - Retinal pigment epithelium

UR - http://www.scopus.com/inward/record.url?scp=85045114375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045114375&partnerID=8YFLogxK

U2 - 10.1073/pnas.1717338115

DO - 10.1073/pnas.1717338115

M3 - Article

C2 - 29581279

AN - SCOPUS:85045114375

VL - 115

SP - 3936

EP - 3941

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 15

ER -